HORIZON 2020 The EU Framework Programme for Research and Innovation 2014-2020
description
Transcript of HORIZON 2020 The EU Framework Programme for Research and Innovation 2014-2020
HORIZON 2020 The EU Framework Programme for Research and Innovation 2014-2020
Presentation to NUI Galway10 September 2013Kay Duggan-Walls, Health Research BoardNational Contact Point for Horizon 2020 Health
Proposal for H2020Legislative proposal from Commission was announced 30 November 2011
Part of a drive to create new jobs and growth in Europe
What is Horizon 2020?• Commission proposal for a €80 billion
research and innovation funding programme (2014-2020)
• A core part of Europe 2020, Innovation Union & European Research Area:- Responding to the economic crisis to invest in
future jobs and growth- Addressing people’s concerns about their
livelihoods, safety and environment- Strengthening the EU’s global position in
research, innovation and technology
Horizon 2020 – What’s New• A single programme bringing together three
separate programmes/initiatives*• Coupling research to innovation – from
research to retail, all forms of innovation• Focus on societal challenges facing EU
society, e.g. health, clean energy and transport• Simplified access, for all companies,
universities, institutes in all EU countries and beyond
*The 7th Research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology (EIT)
Priority 1. Excellent science€25bn
Why:• World class science is the
foundation of tomorrow’s technologies, jobs and well-being
• Europe needs to develop, attract and retain research talent
• Researchers need access to the best infrastructures
European Research CouncilFrontier research by the best individual teams
€13,263
Future and Emerging TechnologiesCollaborative research to open new fields of innovation
€3,100
Marie Curie actionsOpportunities for training and career development
€5,752
Research infrastructures including e-infrastructuresEnsuring access to world class facilities
€2,478
Priority 2. Industrial leadership€18bn
Why:• Strategic investments in key
technologies (e.g. advanced manufacturing, micro-electronics) innovation across existing and emerging sectors.
• Europe needs to attract more private investment in research and innovation
• Europe needs more innovative SMEs to create growth and jobs
Leadership in enabling and industrial technologies (ICT, nanotechnologies, materials, biotechnology, manufacturing space)
€13,781
Access to risk financeLeverage private finance and venture capital for research and innovation
€3,538
Innovation in SMEsFostering all forms of innovation in all types of SMEs
€619
Priority 3. Societal challenges€32bn
Why:• Concerns of citizens and
society/EU policy objectives (climate, environment, energy, transport etc.) cannot be achieved without innovation
• Breakthrough solutions come from multi-disciplinary collaborations, including social sciences & humanities
• Promising solutions need to be tested, demonstrated and scaled up
Health, demographic change and wellbeing €8,033
Food security, sustainable agriculture, marine and maritime research & the bio economy
€4,152
Secure, clean and efficient energy €5,782
Smart, green and integrated transport €6,802
Climate action, resource efficiency and raw materials
€3,160
Inclusive, innovative and secure societies €3,819
Horizon 2020 and partnering: an overview
Public private partnerships• Through Joint Technology Initiatives (JTIs) or other formal structures (Art
187)• Through contractual agreements, which provide input for work programmes• Only when criteria met, e.g. clear commitment from private partnersPublic public partnerships:• Through ‘ERA-Nets’ for topping up individual calls/actions (replacing current
ERA-Net, ERA-Net Plus, Inco-Net, Inno-net)• Through participation in joint programmes between Member States (Art.
185)• Supporting agendas of Joint Programming Initiatives when in line with
Horizon 2020• Only when criteria met, e.g. financial commitments of participating
countriesEuropean Innovation Partnerships• Not funding instruments, but for coordination with broader policies and
programmes
FP7 Cooperation themes → HORIZON2020 challenges1. Health (€6.1b)2. Food, agriculture, fisheries and
biotechnology3. Information and communication
technologies4. Nanosciences,
nanotechnologies, materials and new production technologies
5. Energy
6. Environment (including climate change)
7. Transport (including aeronautics)
8. Socio-economic sciences and the humanities
9. Security 10. Space
• The Health, Demographic Change and Well-being Challenge (€7bn over 7 yrs)
• The Food Security and Bio-based Economy Challenge
• The Secure, Clean and Efficient Energy Challenge
• The Smart, Green and Integrated Transport challenge
• The Resource Efficiency and Climate Challenge
• The Inclusive, Innovative and Secure Societies Challenge
The Health, Demographic Change and Well-being Challenge• Basic research through translation of
knowledge, to large trials and demonstration actions
• Broader scope than FP7• More ICT aspects• Public procurement for new products,
services, scalable solutions (interoperable and supported by defined standards and/or common guidelines) – haven’t had this before in Health
Specific activities proposed 1.1. Understanding health, wellbeing and disease1.1.1. Understanding the determinants of health, improving health promotion and disease prevention1.1.2. Understanding disease1.1.3. Improving surveillance and preparedness1.2. Preventing disease1.2.1. Developing effective prevention and screening programmes and improving the assessment of disease susceptibility1.2.2. Improving diagnosis and prognosis1.2.3. Developing better preventive and therapeutic vaccines1.3. Treating and managing disease1.3.1. Treating disease, including developing regenerative medicine1.3.2. Transferring knowledge to clinical practice and scalable innovation actions
Specific Activities proposed1.4. Active ageing and self-management of health1.4.1. Active ageing, independent and assisted living1.4.2. Individual awareness and empowerment for self-management of health1.5. Methods and data1.5.1. Improving health information and better use of health data1.5.2. Improving scientific tools and methods to support policy making and regulatory needs1.5.3. Using in-silico medicine for improving disease management and prediction1.6. Health care provision and integrated care1.6.1. Promoting integrated care1.6.2. Optimising the efficiency and effectiveness of healthcare provision and reducing inequalities by evidence based decision making and dissemination of best practice, and innovative technologies and approaches
Proposed Work Programme Cycle2014 2015 2016 2017 2018 2019 2020
Strategic Programme
Work Programme 1(plus tentative information for 2016)
Strategic Programme
Work Programme 2(plus tentative information for 2018)
Strategic Programme
Work Programme 3(plus tentative information for 2020)
Work Programme 4
Horizon 2020 Work ProgrammeHorizon 2020 is different
• Multidisciplinary approach• Strong challenge based approach – allowing
applicants freedom to come up with innovative solutions
• Simplified list of possible type of action (research and innovation 100%; innovation actions – 70%)
• Less prescription, strong emphasis on expected impact
• Broader topics• Cross-cutting issues mainstreamed (e.g. social
science, gender)
Personalised Health and Care• Choice to focus on personalised health and care –
informed by ageing of the European population• Increasing communicable and non-communicable
disease burden • Fall out from economic crisis
• Aims to create opportunities for real breakthrough research and radical innovation Supporting translational of findings into clinic and other
healthcare settings to improve health outcomes, reduce inequalities and promote active and healthy ageing
Rational for 1st Work Programme• Demographic changes• Chronic diseases• Sustainability of health and care systems
– cost of inaction• Drug development pipeline• Infectious disease – in terms of global
development, resurgence, pandemic threat
• Big data
Work programme TopicsStructure reflects the challenge based approach1. Specific Challenge – sets the context, the
problem to be addressed, why intervention is necessary
2. Scope – delineates the problem, specifies the focus and the boundaries of the potential action BUT without overtly describing specific approaches
3. Expected Impact – describe the key elements of what is expected to be achieved in relation to the specific challenge
Work Programme Summary• Understanding health, ageing and disease – 2 topics• Effective health promotion, disease prevention,
preparedness and screening – 6 topics• Improving diagnostics – 3 topics• Innovative treatments and technologies – 6 topics• Advancing active and healthy ageing – 3 topics• Integrated, sustainable, citizen-centred care – 7
topics• Improving health information, data exploitation and
providing an evidence-base for health policies and regulation – 5 topics
Work Programme• Societal challenge ‘Health demographic
change and wellbeing’• 2014 & 2015, 32 topics the ‘personalised
health and care’ focus area call• 10 topics in the ‘co-ordination activities’
call
Work Programme Topics• PCH 1 – 2014 Understanding health, ageing
and disease: determinants, risk factors and pathways
• PCH 2 – 2015 Understanding health, ageing and disease: systems medicine
• PCH 3 – 2015 Health promotion and disease prevention: improved inter-sector cooperation for environment and health based interventions
• PHC 4 – 2015 Health promotion and disease prevention: translating ‘omics’ into stratified approaches
Work Programme Topics cont.• PHC 5 – 2014 Evaluating existing screening and
prevention programmes• PHC 6 – 2014 Improving the control of infectious
epidemics and foodborne outbreaks through rapid identification of pathogens
• PHC 7 – 2014 Vaccine development for poverty-related and neglected infectious diseases: Tuberculosis
• PHC 8 – 2015 Vaccine development for poverty-related and neglected infectious diseases – HIV/AIDS
• PHC 9 – 2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
• PHC 10 – 2015 Development of new diagnostic tools and technologies: in vivo medical imaging technologies
Work Programme cont.• PHC 11 – 2014 and 2015 Clinical validation of
biomarkers• PHC 12 – 2014 New therapies for chronic and
non-communicable diseases• PHC 13 – 2015 New therapies for rare diseases• PHC 14 – 2014/15 Clinical research on
regenerative medicine• PHC 15 – 2015 Tools and technologies for
advanced therapies• PHC 16 – 2014 Comparing the effectiveness of
existing healthcare interventions in the elderly
Work Programme cont.• PHC 17 -2015 Establishing effectiveness of health
care interventions in the paediatric population• PHC 18 – 2014 Advancing active and healthy
ageing with ICT: Service robotics within assisted living environments; and ICT solutions for independent living with cognitive impairment
• PHC 19 – 2015 Advancing active and healthy ageing with ICT: Early risk detection and intervention
• PHC 20 – 2015 Promoting mental wellbeing: in the ageing population
Work Programme cont.• PHC 21 – 2014 Developing and comparing new models for
safe and efficient, prevention orientated, health and care systems
• PHC 22 – 2015 Piloting personalised medicine in health and care systems
• PHC 23 – 2015 Advanced ICT systems and services for integrated care
• PHC 24 – 2014 Self-management of health and disease: citizen engagement and mHealth
• PHC 25 – 2015 Self-management of health and disease: decisional support systems and patient empowerment supported by ICT
• PHC 26 – 2015 Public procurement of innovative eHealth services
Work Programme cont.• PHC 27 201? eHealth Sectoral Prize• PHC 28 – 2015 Digital representation of health
data to improve diseases’ diagnosis and treatment
• PHC 29 – 2014 Foresight for health policy development and regulation
• PHC 30 – 2014 Advancing bioinformatics to meet biomedical and clinical needs
• PHC 31 – 2015 New approaches to improve predictive human safety testing
• PHC 32 – 2014 eHealth interoperability
Co-ordination activities• HCO 1 - 2014 Innovative Partnership: Support for the
European Innovative Partnership on Active and Health ageing
• HCO 2 – 2014 Joint Programming: Coordination Action for the Joint Programming Initiative (JPI) ‘More Years, Better Lives – the Challenges and Opportunities of Demographic Change’
• HCO 3 – 201? Support for the European Reference Networks: Efficient network modelling and validation
• HCO 4 – 2014 Support for international infectious disease preparedness research
• HCO 5 – 201? Global Alliance for Chronic Diseases: Prevention and treatment type 2 diabetes
ERA-NETs• HCO 6 – 2014 ERA-NET Establishing synergies
between the Joint Programming on Neurodegenerative Disease Research and Horizon 2020
• HCO 7 – 2014 ERA-NET: Cancer research programmes and activities
• HCO 8 – 2014 ERA-NET: Brain related diseases research programmes and activities
• HCO 9 – 2014 ERA-NET: Systems medicine for clinical needs research programme and activities
• HCO 10 – 201? ERA-NET: Rare disease research implementing IRDiRC objectives
Budget• Horizon 2020 - €70bn over 7 years• SC1 (health) - €7bn over 7 yearsfirst 2 years – only €1bn across 32 topics• 15% of budget ICT topics• 1/3 of funding will be provided for ERA-
NETs
Horizon 2020 is different• Web portal with one entrance for the
Programme• Counting on MS to explain to researchers
– need to look at entirety of the programme not just SC1
• ERC – increase in budget to €15.6bn- 20% ~ life sciences – may be first port of call
• Encouraged to look at other schemes
Timeline • Commission published Horizon 2020 package on 30 Nov 2011• Council agreed ‘Partial General approaches’ on Regulation in May; on
the Rules in October and the Specific Programme in December 2012• The ITRE Committee of Parliament proposed amendments in
November 2012• ‘Adoption of Horizon 2020 legislative acts expected at end 2013• First calls: expected mid-December
• Structure H2020 programme committees to be agreed• Health Advisory Groups to be established• Nominations for NCPs have been sought
Ireland’s Results FP7 Health• 490 participations• 28 successful coordinators• 117 successful partners• 15.5% funding ~ 4 clinical trials projects
• Total funding in FP7 Health - €77.68m
• Ireland target €600 million ~ €502 million• Health target 1.25% - exceeded 1.7%
FP7 Call 1 2007A
FP7 Call 2 2007B
FP7 Call 3 2009 FP7 Call 4 2010 FP7 Call 5 2011 FP7 Call 6 2012 FP7 Call 7 2013
Second Stage Second Stage Second StageNumber of individual participations
- Partners - Coordinators
74
713
93
8211
71
647
62
4913
58
4810
58
4414
74
63
11
Successful coordinators 0 4 1 7 3 10‡ 3
Successful partners¥ 17 15 13 9 20 21 22
Project Success rate 24% 24% TS*50%$ TS* 80%$ TS* 40.9% Innov1# 42.5%, Innov2& 60%
Innov1# 43%Innov2& 0%
EU success rate 17% 20% TS*42%$ TS* 41%$ TS* 41%$ Innov1# 39%, Innov2& 42%
Innov1# 35%Innov2& 32%
Total Budget available €637m €549m €591m €628m €662m €657.6m €819.3m
Total Funding to Ireland €6m €5.88m €4.4m €17.4 €13.6 €18.6 €11.8
Ireland’s FP7 Health Participation 2007-2013 €77.68m
** TS = Two stage , $ at second stage, # Innovation 1 call, & Innovation 2 call (SME focused), ¥ Some projects have multiple Irish Partners, ‡ Highest success rate for coordinators in EU (71.4%)
Health NCPs for Ireland• Kay Duggan-WallsHealth Research [email protected]• Ciaran DuffyEnterprise [email protected]• Patricia Clarke (National Delegate)Health Research [email protected]• Meet regularly – meetings/teleconference/email